Arş. Gör. ASLIHAN AVANOĞLU GÜLER

Yayın Ağı

Makaleler 30

1. Effect of MEFV mutations and HLA-B27 on clinical findings of familial Mediterranean fever and spondyloarthritis

Yuce Inel T., AVANOĞLU GÜLER A., YAŞAR BİLGE N. Ş., KAŞİFOĞLU T., TUFAN A., SARI İ.

Medicine , cilt.104, sa.43, 2025 (SCI-Expanded, Scopus)

2. The effect of self-management program performed via telerehabilitation on occupational performance and satisfaction of individuals with systemic sclerosis

Karakus E., SARİ F., AVANOĞLU GÜLER A., OSKAY D., ÖKSÜZ Ç.

BRITISH JOURNAL OF OCCUPATIONAL THERAPY , cilt.88, sa.3, ss.185-192, 2025 (SCI-Expanded, SSCI, Scopus)

3. The Effect of Telerehabilitation-Based Self-Management Programme on Individuals With Scleroderma

Karakus E., SARİ F., AVANOĞLU GÜLER A., OSKAY D., ÖKSÜZ Ç.

MUSCULOSKELETAL CARE , cilt.22, sa.4, 2024 (ESCI, Scopus)

4. Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands

AVANOĞLU GÜLER A., Campochiaro C., De Luca G., Hughes M., TUFAN A., Green L., et al.

Seminars in Arthritis and Rheumatism , cilt.66, 2024 (SCI-Expanded, Scopus)

5. Frequency of sarcopenia in Turkish women with systemic lupus erythematosus

BİLİCİ SALMAN R., Candemir B., SATIŞ H., ALP G. T., YILDIRIM BORAZAN F., Deniz O., et al.

LUPUS SCIENCE & MEDICINE , cilt.11, sa.1, 2024 (SCI-Expanded, Scopus)

6. Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients.

AVANOĞLU GÜLER A., ÖZÇİMEN B., Aydoğdu M. S., Sari A., Numune A., TÜZÜN ERSAN N., et al.

Turkish journal of medical sciences , cilt.54, sa.1, ss.76-85, 2023 (SCI-Expanded, Scopus, TRDizin)

7. Venous inflammation might be one of the features of VEXAS syndrome and associated thrombosis

KARADENİZ H., CERİT M. N., AVANOĞLU GÜLER A., TUFAN A., Kanthi Y.

RHEUMATOLOGY , cilt.62, 2023 (SCI-Expanded, Scopus)

8. COVID-19 in familial Mediterranean fever: Clinical course and complications related to primary disease

AVANOĞLU GÜLER A., YÜCE İNEL T., KAŞİFOĞLU T., COŞKUN C., KARADENİZ H., YILDIRIM D., et al.

MODERN RHEUMATOLOGY , cilt.33, ss.786-791, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Lacrimal gland ultrasonography and elastography as a diagnostic and activity tool for primary Sjogren's syndrome

KARADENİZ H., CERİT M. N., AVANOĞLU GÜLER A., BİLİCİ SALMAN R., SATIŞ H., YILDIRIM D., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.26, sa.6, ss.1083-1090, 2023 (SCI-Expanded, Scopus)

10. Investigation of the value of hematological biomarkers in the clinical differential diagnosis of IgG4-RD

KARADENİZ H., AVANOĞLU GÜLER A., Kardaş R. C., Karadeniz M., PAŞAOĞLU H., KÜÇÜK H., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.3, ss.666-674, 2023 (SCI-Expanded, Scopus, TRDizin)

11. Determination of the Voice Parameters in Adult Individuals With Rheumatoid Arthritis and the Relation of Voice With Depression and Inflammation

Tunç Songur E., Türkcan A. K., KARADENİZ H., AVANOĞLU GÜLER A., YAPAR D., ÖZTÜRK M. A., et al.

Journal of Voice , cilt.36, sa.6, 2022 (SCI-Expanded, Scopus)

12. The impact of anti-TNF treatment on Wnt signaling, noggin, and cytokine levels in axial spondyloarthritis

Atas N., Cakir B., BAKIR F., UÇAR M., SATIŞ H., Guz G. T., et al.

CLINICAL RHEUMATOLOGY , cilt.41, sa.5, ss.1381-1389, 2022 (SCI-Expanded, Scopus)

13. Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis

KARADENİZ H., AVANOĞLU GÜLER A., KOCA G., BİLİCİ SALMAN R., SATIŞ H., Atas N., et al.

CLINICAL RHEUMATOLOGY , cilt.41, sa.4, ss.1169-1176, 2022 (SCI-Expanded, Scopus)

14. Treatment with biologic DMARDs may not adversely affect lung nodules in rheumatoid arthritis patients

KARADENİZ H., CİNDİL E., BABAOĞLU H., AVANOĞLU GÜLER A., BİLİCİ SALMAN R., SATIŞ H., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , cilt.9, 2022 (ESCI, TRDizin)

15. Compliance of Familial Mediterranean Fever Patients With Regular Follow-up Visits and Associated Factors

BİLİCİ SALMAN R., Babaoglu H., SATIŞ H., YAPAR D., AVANOĞLU GÜLER A., KARADENİZ H., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.28, sa.1, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. The Prognostic Value of Lung Injury and Fibrosis Markers, KL-6, TGF-β1, FGF-2 in COVID-19 Patients.

KARADENİZ H., AVANOĞLU GÜLER A., ÖZGER H. S., AYSERT YILDIZ P., ERBAŞ G., BOZDAYI G., et al.

BIOMARKER INSIGHTS , cilt.17, 2022 (ESCI, Scopus)

17. Work productivity impairment in patients with familial Mediterranean fever and effects of interleukin-1 antagonists

Suticen E., Atas N., AVANOĞLU GÜLER A., AKDOĞAN O., Babaoglu H., SATIŞ H., et al.

CLINICAL RHEUMATOLOGY , cilt.40, sa.7, ss.2865-2871, 2021 (SCI-Expanded, Scopus)

18. Predictors of persistent inflammation in familial Mediterranean fever and association with damage

Babaoglu H., Armagan B., BODAKÇİ E., SATIŞ H., Atas N., Sari A., et al.

RHEUMATOLOGY , cilt.60, sa.1, ss.333-339, 2021 (SCI-Expanded, Scopus)

19. Parotid elastography: a potential alternative to replace labial biopsy in classification of patients with primary Sjögren's syndrome?

Satış H., Cindil E., Salman R. B., Yapar D., Demir N. B., Temel E., et al.

Clinical rheumatology , cilt.39, sa.12, ss.3707-3713, 2020 (SCI-Expanded, Scopus)

20. Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero

SATIŞ H., Salman R. B., AVANOĞLU GÜLER A., KARADENİZ H., YILDIZ Ş., Kayahan N.

ANNALS OF THE RHEUMATIC DISEASES , cilt.79, sa.8, 2020 (SCI-Expanded, Scopus)

21. Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis-related interstitial lung disease: data from the NEREA Registry

SATIŞ H., Oruc A., Avcu A., KARADENİZ H., AVANOĞLU GÜLER A., Kayahan N.

RHEUMATOLOGY , cilt.59, sa.8, ss.2180, 2020 (SCI-Expanded, Scopus)

22. Use of prognostic nutritional index in the evaluation of disease activity in patients with Behcet's disease

Atas N., Babaoglu H., Demirel E., ÇELİK B., Salman R. B., SATIŞ H., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , cilt.7, sa.3, ss.99-104, 2020 (ESCI, TRDizin)

23. Diaphragmatic muscle thickness and diaphragmatic function are reduced in patients with systemic lupus erythematosus compared to those with primary Sjögren's syndrome.

Satış H., Cindil E., Salman R. B., Yapar D., Ülgen Temel E., Demir N. B., et al.

Lupus , cilt.29, sa.7, ss.715-720, 2020 (SCI-Expanded, Scopus)

24. Inter-rater reliability of modified hand mobility in scleroderma test

TORE N. G., SARİ F., Sarac D. C., Yentur S. B., SATIŞ H., AVANOĞLU GÜLER A., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.23, sa.2, ss.203-206, 2020 (SCI-Expanded, Scopus)

25. Familial Mediterranean fever is associated with a wide spectrum of inflammatory disorders: results from a large cohort study

Atas N., Armagan B., Bodakci E., SATIŞ H., Sari A., Bilge N. S. Y., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.40, sa.1, ss.41-48, 2020 (SCI-Expanded, Scopus)

26. Tofacitinib for the treatment for colchicine-resistant familial Mediterranean fever: case-based review

KARADENİZ H., AVANOĞLU GÜLER A., Atas N., SATIŞ H., Salman R. B., Babaoglu H., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.40, sa.1, ss.169-173, 2020 (SCI-Expanded, Scopus)

27. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs

TUFAN A., AVANOĞLU GÜLER A., Matucci-Cerinic M.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.50, ss.620-632, 2020 (SCI-Expanded, Scopus, TRDizin)

28. COVID-19 in Chronic Diseases

AVANOĞLU GÜLER A., ÖZTÜRK M. A.

GAZI MEDICAL JOURNAL , cilt.31, ss.266-270, 2020 (ESCI, Scopus)

29. Comment on: Short-term follow-up results of children with familial Mediterranean fever after cessation of colchicine: is it possible to quit?

SATIŞ H., Senkalfa A., KARADENİZ H., AVANOĞLU GÜLER A., Salman R. B., Kayahan N., et al.

RHEUMATOLOGY , cilt.58, sa.10, ss.1886, 2019 (SCI-Expanded, Scopus)

30. Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register

SATIŞ H., Can G. E., Salman R. B., AVANOĞLU GÜLER A., KARADENİZ H., TUFAN A.

RHEUMATOLOGY , cilt.58, sa.8, ss.1509-1510, 2019 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 11

1. Sistemik lupus eritematozuslu hastalarda gebelik sonuçları ve takrolimus deneyimi

VASİ İ., YILDIRIM D., KARDAŞ R. C., ÖZKIZILTAŞ B., DURAN R., Alp G. T., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 Ekim 2022, (Tam Metin Bildiri)

2. Merkezimizde takipli erişkin başlangıçlı Still hastalığı olanların tedavi yanıtları

YILDIRIM D., VASİ İ., ÖZKIZILTAŞ B., KARDAŞ R. C., AVANOĞLU GÜLER A., KARADENİZ H., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 Ekim 2022, (Tam Metin Bildiri)

3. EVALUATING THE CLINICAL UTILITY OF PATIENT ACCEPTABLE SYMPTOM STATE IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

DEMİREZEN A., AVANOĞLU GÜLER A., KARADENİZ H., YILDIRIM D., KÜÇÜK H., ÖZTÜRK M. A., et al.

EULAR (Avrupa Romatoloji Kongresi), Danimarka, 01 Haziran 2022, (Özet Bildiri)

4. DETERMINING THE RELATIONSHIP BETWEEN SERUM INTERLEUKIN 33 LEVELS AND CLINICAL FEATURES OF THE DISEASE IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

DEMİREZEN A., AVANOĞLU GÜLER A., KARADENİZ H., YILDIRIM D., KÜÇÜK H., KAVUTÇU M., et al.

EULAR (Avrupa Romatoloji Kongresi), Danimarka, 01 Haziran 2022, (Özet Bildiri)

5. Ailesel Akdeniz ateşi hastalarındakronik artrit: Klinik özellikler ve tedavi

AVANOĞLU GÜLER A., COŞKUN Ç., ÜNAL S., Tahta E., KARADENİZ H., Salman R. B., et al.

Ulusal Romatoloji Kongresi 2021, Antalya, Türkiye, 29 Eylül 2021, (Tam Metin Bildiri)

6. Sistemik lupus eritematozusda prognostik nutrisyonel indeksin hastalık aktivitesi ile olan ilişkisinin araştırılması: Tek merkez deneyimi

Salman R. B., AVANOĞLU GÜLER A., KARADENİZ H., SATIŞ H., KÜÇÜK H., HAZNEDAROĞLU Ş., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 29 Eylül 2021, (Tam Metin Bildiri)

7. Bağ dokusu ilişkili intertisyel akciğer hastalığındasiklofosfamid tedavisi sonrası idame tedavisi:Mikofenolat mofetil ile azatiyoprinin karşılaştırılması

SATIŞ H., onut m., bilici salman r., BABAOĞLU H., ATAŞ N., AVANOĞLU GÜLER A., et al.

Ulusal romatoloji kongresi, Türkiye, 17 - 22 Ekim 2020, (Tam Metin Bildiri)

8. POTENTIAL ROLE OF PAROTID ELASTOGRAPHY IN DIAGNOSIS AND CLASSIFICATION OF PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME

SATIŞ H., DEMİR B. N., BİLİCİ SALMAN R., TEMEL E., BABAOĞLU H., ATAŞ N., et al.

ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY, Madrid, İspanya, 12 - 15 Haziran 2019, (Tam Metin Bildiri)

9. POTENTIAL ROLE OF PAROTID ELASTOGRAPHY IN DIAGNOSIS AND CLASSIFICATION OF PATIENTS WITH PRIMARY SJOGREN'S SYNDROME

SATIŞ H., Demir B. N., Salman R. B., ÜLGEN TEMEL E., Babaoglu H., Atas N., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1740, (Özet Bildiri)

10. DIAGNOSTIC UTILITY OF POSITRON EMISSION TOMOGRAPHY FOR THE EVALUATION OF PATIENTS WITH INFLAMMATION OF UNKNOWN ORIGIN

Salman R. B., Gulbahar S., SATIŞ H., Atas N., Babaoglu H., KARADENİZ H., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1360-1361, (Özet Bildiri)

11. FREQUENCY, CHARACTERISTICS AND CLINICAL DETERMINANTS OF "PRODROME" IN FAMILIAL MEDITERRANEAN FEVER PATIENTS

Babaoglu H., Atas N., Varan O., SATIŞ H., Salman R. B., AVANOĞLU GÜLER A., et al.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.585, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

378

H-İndeks (WoS)

Atıf (Scopus)

562

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler